PIPERNO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 18.686
EU - Europa 7.558
AS - Asia 7.398
SA - Sud America 1.140
AF - Africa 111
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 34.912
Nazione #
US - Stati Uniti d'America 18.302
SG - Singapore 2.761
CN - Cina 2.121
HK - Hong Kong 1.369
RU - Federazione Russa 1.302
SE - Svezia 1.084
DE - Germania 1.060
IE - Irlanda 961
BR - Brasile 919
IT - Italia 862
UA - Ucraina 846
GB - Regno Unito 442
VN - Vietnam 423
CA - Canada 317
FI - Finlandia 252
FR - Francia 198
IN - India 151
AT - Austria 150
KR - Corea 99
AR - Argentina 88
TR - Turchia 81
NL - Olanda 76
BD - Bangladesh 64
BE - Belgio 62
DK - Danimarca 58
JP - Giappone 58
ID - Indonesia 56
PL - Polonia 48
ZA - Sudafrica 46
IQ - Iraq 41
MX - Messico 41
ES - Italia 34
PK - Pakistan 32
PE - Perù 29
BG - Bulgaria 28
EC - Ecuador 28
LT - Lituania 22
CO - Colombia 21
SA - Arabia Saudita 21
CL - Cile 17
VE - Venezuela 17
IR - Iran 15
PY - Paraguay 14
UZ - Uzbekistan 14
MA - Marocco 13
KE - Kenya 12
RO - Romania 12
DO - Repubblica Dominicana 10
EG - Egitto 10
AU - Australia 9
CH - Svizzera 9
CZ - Repubblica Ceca 9
MY - Malesia 9
NP - Nepal 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
IL - Israele 8
TN - Tunisia 8
TW - Taiwan 8
KZ - Kazakistan 7
EU - Europa 6
GR - Grecia 6
AM - Armenia 5
NO - Norvegia 5
AZ - Azerbaigian 4
BO - Bolivia 4
ET - Etiopia 4
HR - Croazia 4
JO - Giordania 4
KG - Kirghizistan 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
HU - Ungheria 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
JM - Giamaica 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
Totale 34.890
Città #
Ann Arbor 3.013
Woodbridge 1.748
Singapore 1.675
Fairfield 1.438
Ashburn 1.433
Hong Kong 1.359
Houston 1.343
Chandler 1.026
Dublin 929
Jacksonville 909
Wilmington 751
Frankfurt am Main 651
Seattle 577
Dearborn 565
Cambridge 514
New York 394
Princeton 361
Santa Clara 338
Beijing 336
Milan 265
Nanjing 236
Los Angeles 233
Dallas 187
Hefei 185
Shanghai 182
Lawrence 174
Lachine 155
Altamura 134
Vienna 126
The Dalles 123
Moscow 112
Ho Chi Minh City 108
Buffalo 101
Chicago 97
San Diego 93
São Paulo 93
Seoul 91
Hanoi 84
Nanchang 75
Munich 73
Council Bluffs 70
Andover 67
Shenyang 65
Guangzhou 64
Hebei 54
Toronto 53
Brussels 52
Helsinki 48
Jinan 48
Boardman 47
Dong Ket 47
Changsha 46
London 45
Ottawa 44
Jakarta 41
Tianjin 40
Turku 40
Jiaxing 39
Rio de Janeiro 38
Falls Church 36
Salt Lake City 34
Tokyo 34
Zhengzhou 33
Belo Horizonte 32
Brooklyn 32
Warsaw 31
Montreal 30
Phoenix 30
Nuremberg 29
Rome 27
Columbus 26
Mountain View 24
Norwalk 24
Denver 23
Fremont 23
Ningbo 23
Boston 22
Johannesburg 21
Plovdiv 21
Tampa 21
Huizen 19
Stockholm 19
Campinas 18
Hangzhou 18
Kunming 18
Orem 18
Philadelphia 18
Chennai 17
Curitiba 17
Elk Grove Village 17
Turin 17
Auburn Hills 16
Brasília 16
Dhaka 16
Porto Alegre 16
Chengdu 15
Detroit 15
Mexico City 15
Poplar 15
Taizhou 15
Totale 24.146
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 590
Hepcidin regulation in a mouse model of acute hypoxia 515
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 378
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 359
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 352
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 332
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 329
Hif1a: A putative modifier of hemochromatosis 319
Juvenile Hemochromatosis 314
Inherited iron overload disorders 295
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 285
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 285
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 281
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 275
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 275
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 274
Hepcidin regulation in a mouse model of acute hypoxia 271
Idiopathic erythrocytosis: a germline disease? 270
Circulating factors are involved in hypoxia-induced hepcidin suppression 270
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 269
Type 3 hemochromatosis and beta-thalassemia trait 267
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 264
Unexplained isolated hyperferritinemia without iron overload 259
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 258
Early impairment of large artery structure and function in Type I diabetes mellitus 257
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 247
Hyperferritinemia and diagnosis of type 1 Gaucher disease 247
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 247
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 245
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 238
Hepatocellular carcinoma in Gaucher disease: an international case series 238
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 236
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 235
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 234
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 234
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 231
Ferroportin disease: A novel SLC40A1 mutation 228
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 226
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 225
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 224
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 224
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 223
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 223
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 222
Increased serum ferritin is common in men with essential hypertension 221
Ceruloplasmin variants might have different effects in different iron overload disorders 221
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 218
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 217
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 216
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 216
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 214
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 214
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 214
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 213
Different cortical excitability profiles in hereditary brain iron and copper accumulation 212
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 211
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 210
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 209
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 208
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 208
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 205
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 204
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 203
The iron status of Italian subjects with beta-thalassemia trait 203
Commentary 202
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 202
Homozygous deletion of HFE: The Sardinian hemochromatosis? 201
Biochemical and genetic defects underlying human congenital hypotransferrinemia 201
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 200
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 200
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 198
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 197
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 197
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 196
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 193
Effects of hypobaric hypoxia at high altitude on humoral regulation of blood pressure and body fluids. results of highcare project 193
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 191
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 188
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 188
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 188
Erythrocyte ferritin in thalassemia syndromes 187
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 187
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 187
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 187
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 186
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 186
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 185
Erythrocyte ferritin in patients on chronic hemodialysis treatment 185
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 185
Myelodysplastic Syndromes and Iron Chelation Therapy 185
Natural history of juvenile haemochromatosis 182
Haemochromatosis in patients with β-thalassaemia trait 180
Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene 179
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 178
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 177
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (c70r) 177
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 177
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 177
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisons 174
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 174
Totale 23.277
Categoria #
all - tutte 120.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.682 0 0 0 0 0 200 265 190 252 361 179 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20255.730 396 675 231 241 565 176 225 288 740 815 496 882
2025/20266.541 1.331 757 1.018 1.460 1.782 193 0 0 0 0 0 0
Totale 35.686